Publikation: Bispecific antibodies come to the aid of cancer immunotherapy
Lade...
Dateien
Datum
2021
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Gold
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Molecular Oncology. Wiley. 2021, 15(7), pp. 1759-1763. ISSN 1574-7891. eISSN 1878-0261. Available under: doi: 10.1002/1878-0261.12977
Zusammenfassung
Three collaborative studies published by the groups of Vogelstein, Gabelli, and Zhou report the development of specially designed bispecific antibodies that may help in overcoming the limitations of current immunotherapies. The bispecific antibodies have been designed to couple cells harboring HLA-presented tumor-specific antigens from Tp53 mutant or Ras mutant with CD4 and CD8 T cells, thus facilitating immune-mediated clearance of the cancer cells.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690
AMELIO, Ivano, Gerry MELINO, Arnold J. LEVINE, 2021. Bispecific antibodies come to the aid of cancer immunotherapy. In: Molecular Oncology. Wiley. 2021, 15(7), pp. 1759-1763. ISSN 1574-7891. eISSN 1878-0261. Available under: doi: 10.1002/1878-0261.12977BibTex
@article{Amelio2021Bispe-56464, year={2021}, doi={10.1002/1878-0261.12977}, title={Bispecific antibodies come to the aid of cancer immunotherapy}, number={7}, volume={15}, issn={1574-7891}, journal={Molecular Oncology}, pages={1759--1763}, author={Amelio, Ivano and Melino, Gerry and Levine, Arnold J.} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/56464"> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56464"/> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56464/3/Amelio_2-1syym271fngfm8.pdf"/> <dcterms:title>Bispecific antibodies come to the aid of cancer immunotherapy</dcterms:title> <dc:creator>Melino, Gerry</dc:creator> <dcterms:abstract xml:lang="eng">Three collaborative studies published by the groups of Vogelstein, Gabelli, and Zhou report the development of specially designed bispecific antibodies that may help in overcoming the limitations of current immunotherapies. The bispecific antibodies have been designed to couple cells harboring HLA-presented tumor-specific antigens from Tp53 mutant or Ras mutant with CD4 and CD8 T cells, thus facilitating immune-mediated clearance of the cancer cells.</dcterms:abstract> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-09T10:46:54Z</dc:date> <dc:creator>Levine, Arnold J.</dc:creator> <dc:creator>Amelio, Ivano</dc:creator> <dc:contributor>Levine, Arnold J.</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:language>eng</dc:language> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:issued>2021</dcterms:issued> <dc:contributor>Amelio, Ivano</dc:contributor> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <dc:rights>Attribution 4.0 International</dc:rights> <dc:contributor>Melino, Gerry</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56464/3/Amelio_2-1syym271fngfm8.pdf"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-02-09T10:46:54Z</dcterms:available> </rdf:Description> </rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Nein
Begutachtet
Ja